Internal Medicine, Medical Oncology · Atlanta, GA
NPI
1801000260
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
1365c Clifton Rd NE
Atlanta, GA, 30322
Phone (404) 778-0655
Groups this clinician bills Medicare through
Medicare paid, 2024
$40K
698 services
Medicare patients, 2024
232
Average age 72
Drug cost, 2024
$12.3M
1,570 prescriptions
Company payments, 2025
$43K
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Ajay K Nooka was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 185 times for 124 patients. In total Ajay K Nooka billed 698 services in 18 codes, and Medicare paid $40K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-06-02.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 185 | 124 | $12.40 | $2,294 |
| 99214 Office E&M - Established | Office | 130 | 84 | $74.51 | $9,686 |
| 99213 Office E&M - Established | Office | 99 | 82 | $48.17 | $4,769 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 49 | 32 | $13.29 | $651 |
| 99233 Hospital E&M - Subsequent | Facility | 45 | 24 | $95.68 | $4,306 |
| 99214 Office E&M - Established | Facility | 27 | 19 | $65.54 | $1,770 |
| 99205 Office E&M - New | Office | 27 | 27 | $130.17 | $3,515 |
| 99215 Office E&M - Established | Facility | 25 | 12 | $106.88 | $2,672 |
| 99232 Hospital E&M - Subsequent | Facility | 24 | 20 | $63.59 | $1,526 |
| 99215 Office E&M - Established | Office | 24 | 20 | $120.16 | $2,884 |
| 99213 Office E&M - Established | Facility | 14 | 12 | $37.98 | $532 |
| 99205 Office E&M - New | Facility | 13 | 13 | $146.20 | $1,901 |
By year: 2022 $29K for 400 services; 2023 $29K for 382 services; 2024 $40K for 698 services.
Medicare prescription drug claims, 2024
In 2024, the drug Ajay K Nooka prescribed most often to Medicare patients was Lenalidomide, with 164 prescriptions and refills. In total Ajay K Nooka wrote 1,570 Medicare prescriptions that cost $12.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Lenalidomide Generic | 164 | 164 | 33 | $2.3M |
| Pomalyst Pomalidomide | 161 | 161 | 23 | $3.8M |
| Valacyclovir Valacyclovir Hcl | 159 | 340 | 51 | $7,192 |
| Revlimid Lenalidomide | 126 | 126 | 25 | $2.3M |
| Oxycodone Hcl Generic | 121 | 121 | 41 | $723 |
| Acyclovir Generic | 102 | 209 | 27 | $1,263 |
| Ninlaro Ixazomib Citrate | 101 | 101 | 12 | $1.3M |
| Imbruvica Ibrutinib | 62 | 62 | Under 11 | $972K |
| Nivestym Filgrastim-Aafi | 44 | 44 | 33 | $214K |
| Dexamethasone Generic | 33 | 33 | 18 | $353 |
| Zarxio Filgrastim-Sndz | 33 | 33 | 13 | $65K |
| Venclexta Venetoclax | 29 | 29 | Under 11 | $620K |
| Brukinsa Zanubrutinib | 25 | 25 | Under 11 | $368K |
| Entecavir Generic | 25 | 25 | Under 11 | $1,003 |
| Gabapentin Generic | 24 | 33 | Under 11 | $255 |
Brand drugs: 674 claims; generic drugs: 896 claims; opioid claims: 140.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Ajay K Nooka $43K ($37K in general payments such as food, travel and fees and $6,030 for research) from 12 companies. The largest payer was Pfizer Inc. with $13K.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.